CDT Equity Inc. Share Price & Technical Analysis
CDT · $0.81 (-4.71%)
Healthcare / Biotechnology
$0.81
-4.71%
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the trea…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-11% return in Jun, -31% avg return in past 3 year Jun month.
-244% return in 2026, -232% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -16% | -37% | -69% | -54% | -57% | -11% | – | – | – | – | – | – | -244% |
| 25 | -64% | -49% | -33% | -33% | -60% | -29% | -33% | -27% | -49% | -45% | -27% | -30% | -479% |
| 24 | -42% | -1% | 27% | -21% | 0% | -64% | -77% | -47% | -14% | -25% | 20% | -36% | -279% |
| 23 | 1% | 0% | 2% | 1% | 1% | 0% | 1% | -1% | -44% | -70% | 171% | 0% | 61% |
| 22 | – | – | 0% | 0% | 0% | 1% | 0% | 0% | 0% | 1% | 1% | 1% | 3% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.15M
P/E ratio
—
52W high
$610.0
52W low
$0.77
Volume
3,04,719
Beta
1.57
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is CDT Equity Inc. share price today?
- CDT Equity Inc. (CDT) last traded around $0.81 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CDT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CDT. Download the app for real-time alerts.
- How can I analyze CDT Equity Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.